s20098 has been researched along with Sepsis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aslankoc, R; Boztepe, S; Erzurumlu, Y; Kosar, PA; Ozmen, O; Savas, HB; Savran, M; Temel, EN | 1 |
| Ateş, U; Başol, N; Çavuşoğlu, T; Erbaş, O; Meral, A | 1 |
2 other study(ies) available for s20098 and Sepsis
| Article | Year |
|---|---|
Agomelatine could prevent brain and cerebellum injury against LPS-induced neuroinflammation in rats.
Topics: Acetamides; Animals; Antioxidants; Apoptosis; Brain Injuries; Cerebellum; Hippocampus; Inflammation; Lipopolysaccharides; Male; NF-kappa B; Oxidative Stress; Rats; Rats, Wistar; Sepsis; Signal Transduction | 2020 |
Beneficial effects of agomelatine in experimental model of sepsis-related acute kidney injury.
Topics: Acetamides; Acute Kidney Injury; Animals; Blood Urea Nitrogen; Creatinine; Dose-Response Relationship, Drug; Hypnotics and Sedatives; Injections, Intraperitoneal; Male; Malondialdehyde; Models, Animal; Rats; Rats, Sprague-Dawley; Sepsis; Tumor Necrosis Factor-alpha | 2016 |